Company Filing History:
Years Active: 1992
Title: Atsushi Kawamura: Innovator in Monoclonal Antibodies
Introduction
Atsushi Kawamura is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.
Latest Patents
Kawamura holds a patent for "Monoclonal antibodies specific for free N-acetylfuraminic acid and a hybridoma producing a monoclonal antibody specific for free N-acetylneuraminic acid or beta glycoconjugates thereof." This patent describes a hybridoma that can be generated by fusing B cells of lymphocytes obtained from an animal immunized with N-acetylneuraminic acid or a beta-glycoconjugate, along with myeloma cells. This innovation is crucial for advancing research in immunology and therapeutic applications.
Career Highlights
Kawamura is associated with Mect Corporation, where he continues to push the boundaries of scientific research. His work at the company has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Isao Suda and Kinji Takada. Their collective expertise contributes to the innovative environment at Mect Corporation, fostering advancements in biotechnology.
Conclusion
Atsushi Kawamura's contributions to the field of monoclonal antibodies exemplify the vital role of inventors in advancing medical science. His patent and ongoing work at Mect Corporation highlight the importance of innovation in addressing healthcare challenges.